EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Manchester Procedure vs Sacrospinous Hysteropexy for Treatment of Uterine Descent

Rosa A Enklaar, Sascha F M Schulten, Hugo W F van Eijndhoven, Mirjam Weemhoff, Sanne A L van Leijsen, Marijke C van der Weide, Jeroen van Bavel, Anna C Verkleij-Hagoort, Eddy M M Adang, Kirsten B Kluivers, SAM Study Group

JAMA · 15.08.2023 · 330 (7) · 626

DOI: 10.1001/jama.2023.13140 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 15.08.2023. Verfasst von Rosa A Enklaar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Uterine Prolapse. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance In many countries, sacrospinous hysteropexy is the most commonly practiced uterus-preserving technique in women undergoing a first operation for pelvic organ prolapse. However, there are no direct comparisons of outcomes after sacrospinous hysteropexy vs an older technique, the Manchester procedure.

Objective

To compare success of sacrospinous hysteropexy vs the Manchester procedure for the surgical treatment of uterine descent. Design, Setting, and Participants Multicenter, noninferiority randomized clinical trial conducted in 26 hospitals in the Netherlands among 434 adult patients undergoing a first surgical treatment for uterine descent that did not protrude beyond the hymen.

Interventions

Participants were randomly assigned to undergo sacrospinous hysteropexy (n = 217) or Manchester procedure (n = 217). Main Outcomes and Measures The primary outcome was a composite outcome of success, defined as absence of pelvic organ prolapse beyond the hymen in any compartment evaluated by a standardized vaginal support quantification system, absence of bothersome bulge symptoms, and absence of prolapse retreatment (pessary or surgery) within 2 years after the operation. The predefined noninferiority margin was 9%. Secondary outcomes were anatomical and patient-reported outcomes, perioperative parameters, and surgery-related complications.

Results

Among 393 participants included in the as-randomized analysis (mean age, 61.7 years [SD, 9.1 years]), 151 of 196 (77.0%) in the sacrospinous hysteropexy group and 172 of 197 (87.3%) in the Manchester procedure group achieved the composite outcome of success. Sacrospinous hysteropexy did not meet the noninferiority criterion of −9% for the lower limit of the CI (risk difference, −10.3%; 95% CI, −17.8% to −2.8%; P = .63 for noninferiority). At 2-year follow-up, perioperative outcomes and patient-reported outcomes did not differ between the 2 groups.

Conclusions

Based on the composite outcome of surgical success 2 years after primary uterus-sparing pelvic organ prolapse surgery for uterine descent, these results support a finding that sacrospinous hysteropexy is inferior to the Manchester procedure. Trial Registration TrialRegister.nl Identifier: NTR 6978

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelvic Organ ProlapseUterine ProlapseFemaleHumansMiddle AgedGynecologic Surgical ProceduresTreatment OutcomeUterusAged

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Obstetrics and Gynecology, Isala, Zwolle, the Netherlands.
  • Department of Obstetrics and Gynecology, Zuyderland Medical Center, Heerlen, the Netherlands.
  • Department of Obstetrics and Gynecology, Máxima Medical Center, Veldhoven, the Netherlands.
  • Department of Obstetrics and Gynecology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Obstetrics and Gynecology, Amphia Hospital, Breda, the Netherlands.

Zitieren

APA

Enklaar, R. A., Schulten, S. F. M., van Eijndhoven, H. W. F., Weemhoff, M., van Leijsen, S. A. L., van der Weide, M. C., van Bavel, J., Verkleij-Hagoort, A. C., Adang, E. M. M., Kluivers, K. B., & SAM Study Group (2023). Manchester Procedure vs Sacrospinous Hysteropexy for Treatment of Uterine Descent. JAMA, 330(7), 626. https://doi.org/10.1001/jama.2023.13140

Vancouver

Enklaar RA, Schulten SFM, van Eijndhoven HWF, Weemhoff M, van Leijsen SAL, van der Weide MC, et al. Manchester Procedure vs Sacrospinous Hysteropexy for Treatment of Uterine Descent. JAMA. 2023;330(7):626. doi:10.1001/jama.2023.13140

BibTeX
@article{Enklaar2023,
  author = {Enklaar, Rosa A and Schulten, Sascha F M and van Eijndhoven, Hugo W F and Weemhoff, Mirjam and van Leijsen, Sanne A L and van der Weide, Marijke C and van Bavel, Jeroen and Verkleij-Hagoort, Anna C and Adang, Eddy M M and Kluivers, Kirsten B and SAM Study Group, SAM Study Group},
  title = {Manchester Procedure vs Sacrospinous Hysteropexy for Treatment of Uterine Descent},
  journal = {JAMA},
  year = {2023},
  volume = {330},
  number = {7},
  pages = {626},
  doi = {10.1001/jama.2023.13140}
}
Kostenlos starten →